Indivior Pharmaceuticals, Inc. (INDV)
36.55
-0.21
(-0.57%)
USD |
NASDAQ |
May 18, 16:00
36.55
0.00 (0.00%)
After-Hours: 17:18
Indivior Pharmaceuticals Research and Development Expense (Quarterly) : 9.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 10.60M |
| Liquidia Corp. | 12.27M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Viatris, Inc. | 245.20M |
| Theravance Biopharma, Inc. | 5.448M |